Jiangsu Bioperfectus Technologies Co Ltd Capital Reinvestment Ratio

Latest as of September 2025: 1.00x

Jiangsu Bioperfectus Technologies Co Ltd capital reinvestment ratio. Jiangsu Bioperfectus Technologies Co Ltd (688399) has a Capital Reinvestment Ratio of 1.00x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥20.00 Million) in capital expenditures (CN¥20.05 Million). See 688399 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.00x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥20.00 Million
CNY

Capital Expenditures

CN¥20.05 Million
CNY

Data as of

Sep 2025
Most recent filing

Capital Reinvestment Ratio of Jiangsu Bioperfectus Technologies Co Ltd (2016–2024)

Capital reinvestment ratio of Jiangsu Bioperfectus Technologies Co Ltd from 2016 to 2024. This chart tracks Jiangsu Bioperfectus Technologies Co Ltd's Capital Reinvestment Ratio across 8 annual periods. See 688399 financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Jiangsu Bioperfectus Technologies Co Ltd Capital Reinvestment Ratio by Year (2016–2024)

Jiangsu Bioperfectus Technologies Co Ltd capital reinvestment ratio by year from 2016 to 2024. For the full cash flow conversion analysis, see Jiangsu Bioperfectus Technologies Co Ltd (688399) cash conversion ratio.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.43x CN¥145.93 Million CN¥62.86 Million ▲ +141.3%
2022 0.18x CN¥1.96 Billion CN¥350.74 Million ▼ -42.1%
2021 0.31x CN¥985.52 Million CN¥303.62 Million ▲ +114.3%
2020 0.14x CN¥935.88 Million CN¥134.56 Million ▼ -85.5%
2019 0.99x CN¥106.72 Million CN¥105.77 Million ▼ -13.9%
2018 1.15x CN¥85.82 Million CN¥98.74 Million ▲ +141.8%
2017 0.48x CN¥61.59 Million CN¥29.31 Million ▼ -53.0%
2016 1.01x CN¥22.09 Million CN¥22.37 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow